Home
Conditions
Immunoglobulin Light-chain Amyloidosis

Clinical trial condition

Immunoglobulin Light-chain Amyloidosis

Explore clinical trials studying Immunoglobulin Light-chain Amyloidosis. Study availability and eligibility vary by location and protocol.

182 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Immunoglobulin Light-chain Amyloidosis trial results

Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States

Bergan Mercy Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Lenalidomide in Combination With Melphalan and Dexamethasone in Newly-diagnosed Light-chain (AL)-Amyloidosis

NCT00621400

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
Locations: CHRU d'Amiens Amiens, France

CHRU de Lille Lille, France

CHU de Limoges Limoges, France

CHU de Nantes Nantes, France

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

NCT00003331

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Kaplan Cancer Center New York, United States

View Trial Details

Completed

High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis

NCT00002810

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Fox Chase-Temple Cancer Center CCOP Research Base Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

NCT00010283

Conditions: Adnexal Diseases, Amyloidosis, Blast Crisis, +137 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

NCT00005804

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

NCT00255710

Conditions: Amyloidosis, Anemia, Anemia, Refractory, +66 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

NCT00003082

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Arizona Cancer Center Tucson, Arizona, United States

View Trial Details

Completed

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

NCT00017680

Conditions: Amyloidosis, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: Herbert Irving Comprehensive Cancer Center New York, United States

View Trial Details

Completed

Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis

NCT00344526

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Service des Maladies du Sang Lille, France

Service d'Hématologie et de Thérapie cellulaire Limoges, France

Service d'hématologie clinique Nantes, France

Service d'hématologie Clinique, Groupe Hospitalier Pitié-Salpétrière Paris, France

View Trial Details

Immunoglobulin Light-chain Amyloidosis

Immunoglobulin Light-chain Amyloidosis trial results

Related conditions